Sat, Dec 20, 2014, 12:45 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

L & L Energy, Inc. Message Board

nickwilliams614 27 posts  |  Last Activity: Dec 11, 2014 11:42 AM Member since: Dec 5, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Buy a few shares of a penny stock and gift them to your friends.

    A few shares of BLGO can become valuable next year because BioLargo owns the biggest breakthrough in water treatment in decades that will very likely become one of the world's most valuable technologies. And they are moving quickly to commercialization in a $350 billion industry that needs them.

    Sentiment: Strong Buy

  • Attention INFI Shareholders: Strong Buy Alert Just Triggered by Spectacular Growth Reported In 10Q Filing - Explosive Growth Just Beginning

    Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200%+ increase in quarter revenues in its recent 10Q filing.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially. Future growth is unusually large.

    And Millennium’s gross margins are exceptionally high as the equipment and associated costs can pay for themselves in the first 30 days of installation.

    Millennium’s network of 1,300 physician offices is growing dramatically and sales and earnings are in the early part of a steep growth curve. There are over 30,000 primary care offices and most of them are going to want MHCC exclusive diagnostics.

    $6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 30-50 cents Millennium shares are a ground floor opportunity.

    Shares are oversold and exceptionally cheap because the company has paid millions in fees (reported in 10Q) to consultants with shares of stock that they have been selling heavily to convert to cash. This heavy selling has depressed shares prices to a very attractive entry point.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional buying opportunity.

    Recommend taking advantage of current tax selling low price and putting into your portfolio now.

    MHCC 12 month target - $6.00

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200%+ increase in quarter revenues in its recent 10Q filing.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially. Future growth is unusually large.

    And Millennium’s gross margins are exceptionally high as the equipment and associated costs can pay for themselves in the first 30 days of installation.

    Millennium’s network of 1,300 physician offices is growing dramatically and sales and earnings are in the early part of a steep growth curve. There are over 30,000 primary care offices and most of them are going to want MHCC exclusive diagnostics.

    $6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 30-50 cents Millennium shares are a ground floor opportunity.

    Shares are oversold and exceptionally cheap because the company has paid millions in fees (reported in 10Q) to consultants with shares of stock that they have been selling heavily to convert to cash. This heavy selling has depressed shares prices to a very attractive entry point.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional buying opportunity.

    MHCC 12 month target - $6.00.

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200%+ increase in quarter revenues in its recent 10Q filing.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially. Future growth is unusually large.

    And Millennium’s gross margins are exceptionally high as the equipment and associated costs can pay for themselves in the first 30 days of installation.

    Millennium’s network of 1,300 physician offices is projected to grow dramatically and sales and earnings are in the early part of a steep growth curve.

    $6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    There are over 30,000 primary care offices.

    Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 20-40 cents Millennium shares are a ground floor opportunity.

    Shares are oversold and exceptionally cheap because the company has paid millions in fees (reported in 10Q) to consultants with shares of stock that they have been selling heavily to convert to cash. This heavy selling has depressed shares prices to a very attractive entry point.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional buying opportunity.

    MHCC 12 month target - $6.00.

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200%+ increase in quarter revenues in its recent 10Q filing.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially. Future growth is unusually large.

    And Millennium’s gross margins are exceptionally high as the equipment and associated costs can pay for themselves in the first 30 days of installation.

    Millennium’s network of 1,300 physician offices is projected to grow dramatically and sales and earnings are in the early part of a steep growth curve.

    $6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    There are over 30,000 primary care offices.

    Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 20-40 cents Millennium shares are a ground floor opportunity.

    Shares are oversold and exceptionally cheap because the company has paid millions in fees (reported in 10Q) to consultants with shares of stock that they have been selling heavily to convert to cash. This heavy selling has depressed shares prices to a very attractive entry point.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional opportunity.

    MHCC 12 month target - $6.00.

    Sentiment: Strong Buy

  • Attention BDSI Shareholders: Spectacular Healthcare Growth Opportunity Revealed In 10Q Filing - Explosive Growth JUST Beginning

    Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200%+ increase in revenues in its recent 10Q filing.

    Existing and growing revenues reduce risk dramatically.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially. Future growth is unusually large.

    And Millennium’s gross margins are exceptionally high as the equipment and associated costs can pay for themselves in the first 30 days of installation.

    Millennium’s network of 1,300 physician offices is projected to grow dramatically and sales and earnings are in the early part of a steep growth curve.

$6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    There are over 30,000 primary care offices.

Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 20-40 cents Millennium shares are a ground floor opportunity.

    Shares are oversold and exceptionally cheap because the company has paid millions in fees (reported in 10Q) to consultants with shares of stock that they have been selling heavily to convert to cash. This heavy selling has depressed shares prices to a very attractive entry point.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional opportunity.

MHCC 12 month target - $6.00.

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200%+ increase in revenues in its recent 10Q filing.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially.

    Millennium’s gross margins are exceptionally high as the equipment and associated costs typically pays for themselves in the first 30 days of installation.

    Millennium’s network of 1,300 physician offices is projected to grow dramatically and sales and earnings are in the early part of a steep growth curve.

$6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    There are over 30,000 primary care offices.

Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 20 cents Millennium shares are a ground floor opportunity.

    Shares are oversold and exceptionally cheap because the company has paid millions in fees (reported in 10Q) to consultants with shares of stock that they have been selling heavily to convert to cash. This heavy selling has depressed shares prices to a very attractive entry point.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional opportunity.

MHCC 12 month target - $6.00.

    Sentiment: Strong Buy

  • nickwilliams614 nickwilliams614 Nov 23, 2014 9:02 AM Flag

    AOS is a significant value to the oil and gas industry

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported its Sep quarter revenues at $6.3 million versus $489,000, a 1,200% increase.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially.

    Millennium’s gross margins are exceptionally high as the equipment and associated costs typically pays for themselves in the first 30 days of installation.

    Millennium’s network is growing dramatically.

    $6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    There are over 30,000 primary care offices.

    Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 40 cents, Millennium shares are a ground floor opportunity.

    Shares are exceptionally cheap today because the company has paid many professional fees with shares of stock that have depressed shares prices because they have been sold over the past several months.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional opportunity.

    MHCC is a very strong buy!

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200% increase in revenues in its recent 10Q filing.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially.

    Millennium’s gross margins are exceptionally high as the equipment and associated costs typically pays for themselves in the first 30 days of installation.

    Millennium’s network is projected to grow dramatically and sales and earnings are in the early part of a steep growth curve.

    $6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    There are over 30,000 primary care offices.

    Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 40 cents Millennium shares are a ground floor opportunity.

    Shares are exceptionally cheap because the company has paid many bills with shares of stock that have depressed shares prices because they have been sold over the past several months.

    Invest a few minutes of your time to research and confirm an exceptional opportunity.

    Sentiment: Strong Buy

  • Reply to

    BioLargo Is On the Oil Industry’s Radar Again

    by faststocks7 Nov 13, 2014 3:09 PM
    nickwilliams614 nickwilliams614 Nov 18, 2014 3:59 PM Flag

    Investors also eyeing BLGO.

    Sentiment: Strong Buy

  • nickwilliams614 nickwilliams614 Nov 18, 2014 11:51 AM Flag

    BioLargo just awarded another patent.

    Sentiment: Strong Buy

  • nickwilliams614 nickwilliams614 Nov 17, 2014 1:10 PM Flag

    "New Technology" is a credible and widely followed oil patch industry trade journal.

    BioLargo's AOS Filter is positioned to solve some of the biggest water problems in the oil industry and the entire water treatment industry.

    BioLargo has the potential to become a very large company and commercialization looks possible in 2015.

    This really looks big.

    Sentiment: Strong Buy

  • "New Technology", a trade magazine for the giant "Oil Patch" industry has just awarded BioLargo (BLGO) AOS Filter technology with their coveted “New Technology” award.

    The word about the breakthrough AOS Filter technology has been leaking out since early this year, but now with a recognized industry publication featuring BioLargo’s AOS Filter, the big oil companies are likely to be accelerating talks with BioLargo for licensing deals and strategic partnerships/investments.

    The AOS Filter has been validated by the University of Alberta to decontaminate water in seconds versus the hours required by current technology . . . and to require only 1/20th of the operating cost of the closest competing technology.

    This is by far the biggest breakthrough in water decontamination/filtration in decades and is expected to have an enormous impact on every sector of the water treatment industry.

    The University is working with BioLargo and a consortium of large oil companies that are active in Canadian oil sands production to commercialize the AOS Filter in an actual field recovery operation. BioLargo is the Chair of this joint effort.

    Since the AOS Filter is so efficient and so inexpensive to operate and since it is effective against so many pathogens and toxic pollutants, its value is likely to be extraordinary. The water treatment industry is estimated to be over $350 billion today and projected to be in the trillions by 2020.

    BioLargo (BLGO) has been trading between $.40 and $1.24 since April.

    Sentiment: Strong Buy

  • "New Technology", a trade magazine for the giant "Oil Patch" industry has just awarded BioLargo (BLGO) AOS Filter technology with their coveted “New Technology” award.

    The word about the breakthrough AOS Filter technology has been leaking out since early this year, but now with a recognized industry publication featuring BioLargo’s AOS Filter, the big oil companies are likely to be accelerating talks with BioLargo for licensing deals and strategic partnerships/investments.

    The AOS Filter has been validated by the University of Alberta to decontaminate water in seconds versus the hours required by current technology . . . and to require only 1/20th of the operating cost of the closest competing technology.

    This is by far the biggest breakthrough in water decontamination/filtration in decades and is expected to have an enormous impact on every sector of the water treatment industry.

    The University is working with BioLargo and a consortium of large oil companies that are active in Canadian oil sands production to commercialize the AOS Filter in an actual field recovery operation. BioLargo is the Chair of this joint effort.

    Since the AOS Filter is so efficient and so inexpensive to operate and since it is effective against so many pathogens and toxic pollutants, its value is likely to be extraordinary. The water treatment industry is estimated to be over $350 billion today and projected to be in the trillions by 2020.

    BioLargo (BLGO) has been trading between $.40 and $1.24 since April.

    Sentiment: Strong Buy

  • "New Technology", a trade magazine for the giant "Oil Patch" industry has just awarded BioLargo (BLGO) AOS Filter technology with their coveted “New Technology” award.

    The word about the breakthrough AOS Filter technology has been leaking out since early this year, but now with a recognized industry publication featuring BioLargo’s AOS Filter, the big oil companies are likely to be accelerating talks with BioLargo for licensing deals and strategic partnerships/investments.

    The AOS Filter has been validated by the University of Alberta to decontaminate water in seconds versus the hours required by current technology . . . and to require only 1/20th of the operating cost of the closest competing technology.

    This is by far the biggest breakthrough in water decontamination/filtration in decades and is expected to have an enormous impact on every sector of the water treatment industry.

    The University is working with BioLargo and a consortium of large oil companies that are active in Canadian oil sands production to commercialize the AOS Filter in an actual field recovery operation. BioLargo is the Chair of this joint effort.

    Since the AOS Filter is so efficient and so inexpensive to operate and since it is effective against so many pathogens and toxic pollutants, its value is likely to be extraordinary. The water treatment industry is estimated to be over $350 billion today and projected to be in the trillions by 2020.

    BioLargo (BLGO) has been trading between $.40 and $1.24 since April.

    Sentiment: Strong Buy

  • "New Technology", a trade magazine for the giant "Oil Patch" industry has just awarded BioLargo (BLGO) AOS Filter technology with their coveted “New Technology” award.

    The word about the breakthrough AOS Filter technology has been leaking out since early this year, but now with a recognized industry publication featuring BioLargo’s AOS Filter, the big oil companies are likely to be accelerating talks with BioLargo for licensing deals and strategic partnerships/investments.

    The AOS Filter has been validated by the University of Alberta to decontaminate water in seconds versus the hours required by current technology . . . and to require only 1/20th of the operating cost of the closest competing technology.

    This is by far the biggest breakthrough in water decontamination/filtration in decades and is expected to have an enormous impact on every sector of the water treatment industry.

    The University is working with BioLargo and a consortium of large oil companies that are active in Canadian oil sands production to commercialize the AOS Filter in an actual field recovery operation. BioLargo is the Chair of this joint effort.

    Since the AOS Filter is so efficient and so inexpensive to operate and since it is effective against so many pathogens and toxic pollutants, its value is likely to be extraordinary. The water treatment industry is estimated to be over $350 billion today and projected to be in the trillions by 2020.

    BioLargo (BLGO) has been trading between $.40 and $1.24 since April.

    Sentiment: Strong Buy

  • "New Technology", a trade magazine for the giant "Oil Patch" industry has just awarded BioLargo (BLGO) AOS Filter technology with their coveted “New Technology” award.

    The word about the breakthrough AOS Filter technology has been leaking out since early this year, but now with a recognized industry publication featuring BioLargo’s AOS Filter, the big oil companies are likely to be accelerating talks with BioLargo for licensing deals and strategic partnerships/investments.

    The AOS Filter has been validated by the University of Alberta to decontaminate water in seconds versus the hours required by current technology . . . and to require only 1/20th of the operating cost of the closest competing technology.

    This is by far the biggest breakthrough in water decontamination/filtration in decades and is expected to have an enormous impact on every sector of the water treatment industry.

    The University is working with BioLargo and a consortium of large oil companies that are active in Canadian oil sands production to commercialize the AOS Filter in an actual field recovery operation. BioLargo is the Chair of this joint effort.

    Since the AOS Filter is so efficient and so inexpensive to operate and since it is effective against so many pathogens and toxic pollutants, its value is likely to be extraordinary. The water treatment industry is estimated to be over $350 billion today and projected to be in the trillions by 2020.

    BioLargo (BLGO) has been trading between $.40 and $1.24 since April.

    Sentiment: Strong Buy

  • "New Technology", a trade magazine for the giant "Oil Patch" industry has just awarded BioLargo (BLGO) AOS Filter technology with their coveted “New Technology” award.

    The word about the breakthrough AOS Filter technology has been leaking out since early this year, but now with a recognized industry publication featuring BioLargo’s AOS Filter, the big oil companies are likely to be accelerating talks with BioLargo for licensing deals and strategic partnerships/investments.

    The AOS Filter has been validated by the University of Alberta to decontaminate water in seconds versus the hours required by current technology . . . and to require only 1/20th of the operating cost of the closest competing technology.

    This is by far the biggest breakthrough in water decontamination/filtration in decades and is expected to have an enormous impact on every sector of the water treatment industry.

    The University is working with BioLargo and a consortium of large oil companies that are active in Canadian oil sands production to commercialize the AOS Filter in an actual field recovery operation. BioLargo is the Chair of this joint effort.

    Since the AOS Filter is so efficient and so inexpensive to operate and since it is effective against so many pathogens and toxic pollutants, its value is likely to be extraordinary. The water treatment industry is estimated to be over $350 billion today and projected to be in the trillions by 2020.

    BioLargo (BLGO) has been trading between $.40 and $1.24 since April.

    Sentiment: Strong Buy

  • "New Technology", a trade magazine for the giant "Oil Patch" industry has just awarded BioLargo (BLGO) AOS Filter technology with their coveted “New Technology” award.

    The word about the breakthrough AOS Filter technology has been leaking out since early this year, but now with a recognized industry publication featuring BioLargo’s AOS Filter, the big oil companies are likely to be accelerating talks with BioLargo for licensing deals and strategic partnerships/investments.

    The AOS Filter has been validated by the University of Alberta to decontaminate water in seconds versus the hours required by current technology . . . and to require only 1/20th of the operating cost of the closest competing technology.

    This is by far the biggest breakthrough in water decontamination/filtration in decades and is expected to have an enormous impact on every sector of the water treatment industry.

    The University is working with BioLargo and a consortium of large oil companies that are active in Canadian oil sands production to commercialize the AOS Filter in an actual field recovery operation. BioLargo is the Chair of this joint effort.

    Since the AOS Filter is so efficient and so inexpensive to operate and since it is effective against so many pathogens and toxic pollutants, its value is likely to be extraordinary. The water treatment industry is estimated to be over $350 billion today and projected to be in the trillions by 2020.

    BioLargo (BLGO) has been trading between $.40 and $1.24 since April.

    Sentiment: Strong Buy

LLEN
0.070.00(-0.14%)Dec 19 3:51 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST